Treatment Alternatives in iSGS (NoAAC PR-02 Study)
Trial ID or NCT#
Status
Purpose
The study is aimed at answering the questions; (1) How well do the most commonly used treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each approach? With the results of this trial, the investigators hope to provide information to iSGS patients: (1) Given my personal characteristics, conditions, and preferences, what should I expect will happen to me? and (2) What are my options, and what are the potential benefits and harms of these options?
Official Title
Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)
Eligibility Criteria
- - Greater than 18 years of age. - The lesion must involve the subglottis.
- - Less than 18 years of age - Patients without capacity to consent for themselves - History of significant laryngotracheal traumatic injury. - History of endotracheal intubation or tracheotomy within 2 years of presentation. - Major anterior neck surgery. - History of neck irradiation. - History of caustic or thermal injuries to the laryngotracheal complex. - History of a clinically diagnosed vasculitis or collage vascular disease. - Positive antinuclear cytoplasmic antibody titers.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
650-723-5281
View on ClinicalTrials.gov